<DOC>
	<DOCNO>NCT02048683</DOCNO>
	<brief_summary>Comparing pharmacokinetic model short sevoflurane sedation burn ICU patient control ICU patient .</brief_summary>
	<brief_title>A Pharmacokinetic Study Sevoflurane Inhalation Burn ICU Patients</brief_title>
	<detailed_description>Prospective clinical study ICU sedate ventilated patient sevoflurane AnaCondaÂ® system , establish pharmacokinetic model sevoflurane metabolite ( hydroxyfluroisopropanol , fluoride ) compare burn non burn ICU patient</detailed_description>
	<mesh_term>Sevoflurane</mesh_term>
	<criteria>Adult patient ventilate require invasive procedure ICU Stable respiratory hemodynamic condition Consent patient family Arterial line Burn patient : burn area 20 50 % ( 3rd degree ) OR non burn patient BMI &lt; 30 Sevoflurane anaphylaxia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Sevoflurane</keyword>
	<keyword>Burn</keyword>
	<keyword>Sedation</keyword>
</DOC>